Patients with appendiceal adenocarcinoma face increased risk of secondary cancers, including colorectal, within 10 years, per ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

SAN DIEGO - Inhibrx Biosciences, Inc. (NASDAQ: INBX), a clinical-stage biopharmaceutical company valued at $195 million, ...

Treatment for renal cell carcinoma can vary depending on the size of your tumor, your overall health, how advanced your cancer is, and other factors. Some of the options include surgery, radiation ...

1Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: John Paul Shen, Department of Colon and Rectal Surgery, The ...

1Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. 2Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China. 3Key ...

#stankostrong…” On April 29, 2024, Jonathan Stanko received a diagnosis of stage four Adenocarcinoma gastric cancer. On May 10, 2024, he shared his journey in a blog post. Jonathan Stanko ...

Colon cancer symptoms in women include diarrhea, constipation, unintended weight loss, and bloody stools. While these are the same for anyone with colon cancer, symptoms in women may be misattributed ...

pancreatic ductal adenocarcinoma, colorectal cancer. The drug candidate comprises of PurAffin ligands which are chemically stabilized peptide ligands (peptidomimetics) coupled to a therapeutic ...

The company develops drug candidate apatinib, a selective VEGFR-2 inhibitor for the treatment of solid tumor cancers such as metastatic gastric carcinoma, colorectal cancer, hepatocellular carcinoma, ...